AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Glimitos M 0.5mg/500mg Tablet PR

Prescription Icon
Prescription Required

Marketer

Atos Lifesciences Pvt Ltd

Salt Composition

Glimepiride (0.5mg) + Metformin (500mg)

Overview Glimitos M 0.5mg/500mg Tablet PR

Glimitos M 0.5mg/500mg Tablet PR, classified as an antidiabetic medication, combines two active ingredients to manage type 2 diabetes in adults. This medication helps regulate blood glucose levels. Administer Glimitos M with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with well-controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to complications like kidney impairment, vision loss, neuropathy, and limb amputation. This medication is one component of a comprehensive diabetes management plan, which necessitates a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms such as sweating, dizziness, headache, and tremors. Regular meals and readily available fast-acting glucose sources (e.g., sugary foods, fruit juice) are essential to mitigate this risk. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is another possible consequence. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women should seek medical advice prior to use. Regular blood glucose monitoring is vital, and your doctor may order blood tests to assess blood cell counts and liver function.

Primary Ingredients of Glimitos M 0.5mg/500mg Tablet PR

No text provided. Please provide the text you want me to rephrase.

Uses of Glimitos M 0.5mg/500mg Tablet PR

Managing type 2 diabetes

Major Benefits of Glimitos M 0.5mg/500mg Tablet PR:

Follow your physician's instructions or consult the product labeling for administration guidance. Ingest Glimitos M 0.5mg/500mg Tablet PR with a meal.

Common Side effects of Glimitos M 0.5mg/500mg Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimitos M 0.5mg/500mg Tablet PR:

Follow your physician's instructions or consult the product label for proper administration. Consume Glimitos M 0.5mg/500mg Tablet PR with a meal.

How Glimitos M 0.5mg/500mg Tablet PR works:

Glimepiride/Metformin 0.5mg/500mg tablets (PR) combine two distinct anti-diabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol consumption with Glimitos M 0.5mg/500mg Tablet PR is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimitos M 0.5mg/500mg Tablet PR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice before using this medication.

Breast feedingBreast feedingUNSAFE

Lactation and Glimitos M 0.5mg/500mg Tablet PR are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glimitos M 0.5mg/500mg Tablet PR; dosage modification may be necessary. Consult your physician for guidance. Glimitos M 0.5mg/500mg Tablet PR is contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimitos M 0.5mg/500mg Tablet PR cautiously, potentially requiring dosage modification. Consult a physician for guidance. A reduced initial dose is typically prescribed for individuals with mild to moderate hepatic dysfunction; the medication is contraindicated in those with severe liver disease.

What if you forget to take Glimitos M 0.5mg/500mg Tablet PR :

Should you forget a Glimitos M 0.5mg/500mg Tablet PR dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimitos M 0.5mg/500mg Tablet PR

LabelValue
Developing Good Habits No.
Treatment Category Diabetes Management

FAQs on Glimitos M 0.5mg/500mg Tablet PR

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication. Keep out of reach of children, pets, and others.
Glimitos M 0.5mg/500mg Tablet PR can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these symptoms, discontinue Glimitos M 0.5mg/500mg Tablet PR and seek immediate medical attention.
Glimitos M 0.5mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glimitos M 0.5mg/500mg Tablet PR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glimitos M 0.5mg/500mg Tablet PR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate this risk, annual supplementation with an external vitamin B12 source is recommended by some researchers.
Glimitos M 0.5mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimitos M 0.5mg/500mg tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glimitos M 0.5mg/500mg Ta...
83
MRP 96
13% off